Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Savara Secures FDA Agreement for Rare Lung Disease Drug, Plans December BLA Filing With $146M Cash Runway

Summary by stocktitan.net
Savara aligns with FDA on BLA resubmission for autoimmune PAP treatment MOLBREEVI, partnering with Fujifilm for manufacturing. December filing planned with $146M runway. Learn more.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

stocktitan.netstocktitan.net

Savara Secures FDA Agreement for Rare Lung Disease Drug, Plans December BLA Filing With $146M Cash Runway

Savara aligns with FDA on BLA resubmission for autoimmune PAP treatment MOLBREEVI, partnering with Fujifilm for manufacturing. December filing planned with $146M runway. Learn more.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

stocktitan.net broke the news in on Wednesday, August 13, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Fujifilm icon

Fujifilm

United States icon

United States

News
For You
SearchBlindspotLocal